Topamax

Osteoporosis

Janssen Korea, Ltd., KoreaDormant

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 89/ 100

Competitive context

6 Active assets in the Osteoporosis cohort.

Asset / Sponsor	Phase	Rating
RISEDRONIC ACID Susan L. Greenspan	Phase 4	BBB
VITAMIN D Benha University	Phase 4	BBB
Zoledronate California Pacific Medical Center Research Institute	Phase 4	BBB
ALENDRONIC ACID University College Dublin	Phase 4	BBB
Calcium Benha University	Phase 4	BBB

View all 50 →

Same molecule, other indications

Topamax is also rated in:

focal epilepsyDormant

A

Indicative ·

80 / 100

migraine without auraDormant

BBB

Indicative ·

78 / 100

migraine with auraDormant

BBB

Indicative ·

78 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.